Jim Simons Daxor Corp Call Options Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DXR
# of Institutions
8Shares Held
99.7KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA49KShares$556,9580.0% of portfolio
-
Keyes, Stange & Wooten Wealth Management, LLC Palm Coast, FL15.9KShares$180,7830.08% of portfolio
-
Morgan Stanley New York, NY3.56KShares$40,3840.0% of portfolio
-
Sbi Securities Co., Ltd. Tokyo, M03.13KShares$35,5340.0% of portfolio
-
Jpmorgan Chase & CO New York, NY4Shares$450.0% of portfolio
About DAXOR CORP
- Ticker DXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 4,041,670
- Market Cap $45.9M
- Description
- Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...